1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsStroke Data and Clinical Coordinating Center is sponsored by National Institute of Neurological Disorders and Stroke (NINDS). Provides support for data management and coordination of stroke clinical trials.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NINDS Stroke Trials Network - National Clinical Coordinating Center (U01) - Federal Grant NINDS Stroke Trials Network - National Clinical Coordinating Center (U01) The summary for the NINDS Stroke Trials Network - National Clinical Coordinating Center (U01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants. com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact .
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant. NINDS Stroke Trials Network - National Clinical Coordinating Center (U01): The purpose of this funding opportunity announcement (FOA) is to invite applications to participate as a National Clinical Coordinating Center for the NINDS Stroke Trials Network.
The primary goal of this network is to maximize efficiencies to develop, promote and conduct high-quality, multi-site exploratory phase 1, 2 and confirmatory phase 3 clinical trials focused on key interventions, as well as biomarker-validation studies that are immediately preparatory to trials, in stroke prevention, treatment, and recovery with the objective to have a balanced portfolio between all three approaches.
The network will include multiple regional coordinating stroke centers with strong collaborative relationships between vascular neurology, emergency medicine, interventional neuroradiology, neurosurgery, neurointensive care, neuroimaging, stroke rehabilitation, and pediatric neurology that is coordinated through separate National Clinical Coordinating and Data Management Centers.
Efficiency will be encouraged through the use of master trial agreements and a central IRB.
Clinical and basic scientists at the regional coordinating stroke centers will contribute to the development of network clinical trial applications for peer review, as well as planning for execution of NINDS-funded clinical trial applications from outside of the network, including trials that result from Collaborative Research and Development Agreements between the NINDS and Industry partners.
The Network will also be uniquely poised to rapidly collaborate with other existing networks, such as the NINDS Neurological Emergencies Treatment Trials Network (NETT) or international consortia to conduct larger, definitive trials of promising interventions for the treatment of stroke.
NINDS Stroke Trials Network - National Clinical Coordinating Center (U01) National Institutes of Health Funding Opportunity Number: Extramural Research Programs in the Neurosciences and Neurological Disorders Current Application Deadline: Original Application Deadline: Maximum Federal Grant Award: Minimum Federal Grant Award: Expected Number of Awards: Cost Sharing or Matching: Applicants Eligible for this Grant State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification) Additional Information on Eligibility Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact NIH OER [email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [ [email protected] ] Similar Government Grants • Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC... • NINDS Child Neurology Career Development Program (CNCDP) (K12 - Clinical Trial Not Allowed...
• Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 C... • The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed) • Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG...
• NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44) • NINDS Institutional Center Core Grants to Support Neuroscience Research • Career Development Award to Promote Diversity in Neuroscience Research More Grants from the National Institutes of Health • Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial...
• Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC... • Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) • Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal ... • PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine...
Federal Grants by Category Grants for Single Mothers Small Business Grants for Women Federal Grants for College Federal Tuition Assistance
According to the current listing, eligibility includes: Nonprofits, Universities, State/local governments, For-profits. Confirm the full requirements in the official notice before applying.
Stroke Data and Clinical Coordinating Center is funded by National Institute of Neurological Disorders and Stroke (NINDS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The AIR program is ARPA-H's most ambitious bet yet: fully autonomous robots that perform stroke-saving thrombectomies without a human surgeon. Proposals are due March 18. A strategic guide for applicants.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read article